Minoru Satoh

Publication List Details

Period

2003 - 2009

Number

28

Co-Authors

Rapid serological detection of autoantibodies associated with Sjögren's syndrome (2009)

Burbelo, Peter D, Ching, Kathryn H, Issa, Alexandra T, Loftus, Caroline M, Li, Yi, Satoh, Minoru, ...

Abstract Background Sjögren's syndrome (SjS) is a relatively common autoimmune disease characterized by oral and ocular dryness. There is an increasing need for simple, sensitive and rapid...

Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies (2009)

Palafox Sánchez, Claudia, Satoh, Minoru, Chan, Edward KL, Carcamo, Wendy C, Muñoz Valle, José, Orozco Barocio, Gerardo, ...

Abstract Introduction Systemic lupus erythematosus is characterized by production of autoantibodies to RNA or DNA–protein complexes such as small nuclear ribonucleoproteins (snRNPs). A role of...

Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus (2009)

Li, Yi, Lee, Pui Y, Sobel, Eric S, Narain, Sonali, Satoh, Minoru, Segal, Mark S, ...

Abstract Introduction The high-affinity receptor for IgG Fcγ/CD64 is critical for the development of lupus nephritis (LN). Cross-linking Fc receptor on recruited monocytes by IgG-containing immune...

Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients (2008)

Pauley, Kaleb M, Satoh, Minoru, Chan, Annie L, Bubb, Michael R, Reeves, Westley H, Chan, Edward KL

Abstract Introduction MicroRNAs are small noncoding RNA molecules that negatively regulate gene expression via degradation or translational repression of their targeted mRNAs. It is known that...

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy (2008)

Satoh, Minoru, Fujimoto, Sohachi, Arakawa, Sayaka, Yada, Toyotaka, Namikoshi, Tamehachi, Haruna, Yoshisuke, ...

Background Recent studies showed that angiotensin II type 1 receptor blocker (ARB) slows progression of chronic renal disease in patients with type 2 diabetes, regardless of changes in blood...

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases (2006)

Yamasaki, Yoshioki, Narain, Sonali, Hernandez, Liza, Barker, Tolga, Ikeda, Keigo, Segal, Mark S, ...

Abstract Replication protein A (RPA), a heterotrimer with subunits of molecular masses 70, 32, and 14 kDa, is a single-stranded-DNA-binding factor involved in DNA replication, repair, and...

Autoimmune targeting of key components of RNA interference (2006)

Jakymiw, Andrew, Ikeda, Keigo, Fritzler, Marvin J, Reeves, Westley H, Satoh, Minoru, Chan, Edward KL

Abstract RNA interference (RNAi) is an evolutionarily conserved mechanism that is involved in the post-transcriptional silencing of genes. This process elicits the degradation or translational...

Distinctive Patterns of Autoimmune Response Induced by Different Types of Mineral Oil (2004)

Kuroda, Yoshiki, Akaogi, Jun, Nacionales, Dina C., Wasdo, Scott C., Szabo, Nancy J., Reeves, Westley H., ...

Although mineral oils are generally considered nontoxic and have a long history of use in humans, the mineral oil Bayol F (incomplete Freund's adjuvant, IFA) and certain mineral oil components...

Distinctive Patterns of Autoimmune Response Induced by Different Types of Mineral Oil (2004)

Kuroda, Yoshiki, Akaogi, Jun, Nacionales, Dina C., Wasdo, Scott C., Szabo, Nancy J., Reeves, Westley H., ...

Although mineral oils are generally considered non-toxic and have a long history of use in humans, the mineral oil Bayol F (incomplete Freund's adjuvant, IFA) and certain mineral oil components...

X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus (2003)

Satoh, Minoru, Mizutani, Akiei, Behney, Krista M., Kuroda, Yoshiki, Akaogi, Jun, Yoshida, Hideo, ...

Murine lupus can occur spontaneously or be induced by hydrocarbons, such as pristane. Spontaneous disease in MRL and NZB/W F1 mice is suppressed by the xid (X‐linked immunodeficiency) mutation,...

HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats (2003)

Usui, Hitomi, Shikata, Kenichi, Matsuda, Mitsuhiro, Okada, Shinichi, Ogawa, Daisuke, Yamashita, Tetsuji, ...

Background. An inflammatory process may be one of the critical factors that contribute to the development of diabetic nephropathy (DN). We reported previously that intercellular adhesion...

Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt

Mukai, Yasushi, Rikitake, Yoshiyuki, Shiojima, Ichiro, Wolfrum, Sebastian, Satoh, Minoru, Takeshita, Kyosuke, ...

To determine whether endothelial Akt could affect vascular lesion formation, mutant mice with a constitutively active Akt transgene, which could be inducibly targeted to the vascular endothelium...

Requirement of Rac1 in the development of cardiac hypertrophy

Satoh, Minoru, Ogita, Hisakazu, Takeshita, Kyosuke, Mukai, Yasushi, Kwiatkowski, David J., Liao, James K.

The development of cardiac hypertrophy is mediated, in part, by increase in NADPH oxidase activity and myocardial oxidative stress. The Rho GTPase, Rac, regulates NADPH oxidase activity through...

Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt

Mukai, Yasushi, Rikitake, Yoshiyuki, Shiojima, Ichiro, Wolfrum, Sebastian, Satoh, Minoru, Takeshita, Kyosuke, ...

To determine whether endothelial Akt could affect vascular lesion formation, mutant mice with a constitutively active Akt transgene, which could be inducibly targeted to the vascular endothelium...

Requirement of Rac1 in the development of cardiac hypertrophy

Satoh, Minoru, Ogita, Hisakazu, Takeshita, Kyosuke, Mukai, Yasushi, Kwiatkowski, David J., Liao, James K.

The development of cardiac hypertrophy is mediated, in part, by increase in NADPH oxidase activity and myocardial oxidative stress. The Rho GTPase, Rac, regulates NADPH oxidase activity through...

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases

Yamasaki, Yoshioki, Narain, Sonali, Hernandez, Liza, Barker, Tolga, Ikeda, Keigo, Segal, Mark S, ...

Replication protein A (RPA), a heterotrimer with subunits of molecular masses 70, 32, and 14 kDa, is a single-stranded-DNA-binding factor involved in DNA replication, repair, and recombination. There...

Autoimmune targeting of key components of RNA interference

Jakymiw, Andrew, Ikeda, Keigo, Fritzler, Marvin J, Reeves, Westley H, Satoh, Minoru, Chan, Edward KL

RNA interference (RNAi) is an evolutionarily conserved mechanism that is involved in the post-transcriptional silencing of genes. This process elicits the degradation or translational inhibition of...

Type I Interferon Production by Tertiary Lymphoid Tissue Developing in Response to 2,6,10,14-Tetramethyl-Pentadecane (Pristane)

Nacionales, Dina C., Kelly, Kindra M., Lee, Pui Y., Zhuang, Haoyang, Li, Yi, Weinstein, Jason S., ...

Lymphoid neogenesis is associated with antibody-mediated autoimmune diseases such as Sjogren’s syndrome and rheumatoid arthritis. Although systemic lupus erythematosus is the prototypical...

Amelioration of progressive renal injury by genetic manipulation of Klotho gene

Haruna, Yoshisuke, Kashihara, Naoki, Satoh, Minoru, Tomita, Naruya, Namikoshi, Tamehachi, Sasaki, Tamaki, ...

Klotho, an antiaging gene with restricted organ distribution, is mainly expressed in the kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and osteoporesis, features...

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

Haruna, Yoshisuke, Morita, Yoshitaka, Yada, Toyotaka, Satoh, Minoru, Fox, David A., Kashihara, Naoki

Objective To investigate the effect of statins on vascular dysfunction in rat adjuvant-induced arthritis (AIA). Methods Fluvastatin (5 mg/kg/day) was administered orally to rats with AIA, for 21 days...

Small Interfering RNA-mediated Silencing Induces Target-dependent Assembly of GW/P Bodies

Lian, Shangli, Fritzler, Marvin J., Katz, Joseph, Hamazaki, Takashi, Terada, Naohiro, Satoh, Minoru, ...

Gene silencing using small interfering RNA (siRNA) is a valuable laboratory tool and a promising approach to therapeutics for a variety of human diseases. Recently, RNA interference (RNAi) has been...

Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus

Richards, Hanno B., Satoh, Minoru, Shaw, Melody, Libert, Claude, Poli, Valeria, Reeves, Westley H.

Pristane induces a lupus-like syndrome in nonautoimmune mice characterized by the development of glomerulonephritis and lupus-associated autoantibodies. This is accompanied by overproduction of...

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

Satoh, Minoru, Fujimoto, Sohachi, Arakawa, Sayaka, Yada, Toyotaka, Namikoshi, Tamehachi, Haruna, Yoshisuke, ...

Background Recent studies showed that angiotensin II type 1 receptor blocker (ARB) slows progression of chronic renal disease in patients with type 2 diabetes, regardless of changes in blood...

TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus

Lee, Pui Y., Kumagai, Yutaro, Li, Yi, Takeuchi, Osamu, Yoshida, Hideo, Weinstein, Jason, ...

Increased type I interferon (IFN-I) production and IFN-stimulated gene (ISG) expression are linked to the pathogenesis of systemic lupus erythematosus (SLE). Although the mechanisms responsible for...